Gelteq (GELS) Stock Chart & Stock Price History $1.40 +0.05 (+3.70%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisChartCompetitorsHeadlinesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Gelteq Stock Price Performance The Gelteq (GELS) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock decreased 39.66%. In the past month, the stock has increased 9.37%, reflecting recent market activity. As of the latest close, Gelteq traded at $1.35 with a market cap of $12.74 million and volume of 83,014 shares. Receive GELS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Gelteq and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. 5 Day Performance+3.70%1 Month Performance+9.37%3 Month Performance-25.53%Year-To-Date Performance-39.66% GELS Stock Chart for Friday, September, 26, 2025 GELS Chart by TradingView Gelteq Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization09/26/2025$1.35$1.40+3.70%$1.43$1.3731,671 shs$13.22 million09/25/2025$1.45$1.35-6.90%$1.43$1.3583,014 shs$12.74 million09/24/2025$1.38$1.45+5.07%$1.50$1.38107,328 shs$13.69 million09/23/2025$1.37$1.38+0.73%$1.43$1.36212,761 shs$13.03 million09/22/2025$1.35$1.37+1.48%$1.39$1.29116,692 shs$12.93 million09/19/2025$1.46$1.35-7.53%$1.50$1.35219,200 shs$12.74 million09/18/2025$1.54$1.46-5.19%$1.62$1.46158,230 shs$13.78 million09/17/2025$1.53$1.54+0.65%$1.59$1.5150,986 shs$14.54 million09/16/2025$1.42$1.53+7.75%$1.60$1.46111,883 shs$14.44 million09/15/2025$1.60$1.42-11.25%$1.63$1.42129,439 shs$13.41 million Get the Latest News and Ratings for GELS and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Gelteq and its competitors with MarketBeat's FREE daily newsletter. 09/12/2025$1.50$1.60+6.67%$1.67$1.45443,485 shs$15.10 million09/11/2025$1.35$1.50+11.11%$1.59$1.41165,383 shs$14.16 million09/10/2025$1.38$1.35-2.17%$1.65$1.30617,948 shs$12.74 million09/09/2025$1.56$1.38-11.54%$1.54$1.26424,832 shs$13.03 million09/08/2025$1.56$1.56$1.62$1.221.66 million shs$14.73 million09/05/2025$0.96$1.56+62.50%$2.02$0.9071.67 million shs$14.73 million09/04/2025$1.12$0.96-14.29%$1.18$0.82800,771 shs$9.06 million09/03/2025$1.20$1.12-6.67%$1.19$1.1056,009 shs$10.57 million09/02/2025$1.25$1.20-4.15%$1.25$1.1545,548 shs$11.33 million09/01/2025$1.25$1.25$1.32$1.2424,370 shs$11.82 million08/29/2025$1.30$1.25-3.69%$1.32$1.2424,370 shs$11.82 million08/28/2025$1.33$1.30-2.26%$1.33$1.2817,408 shs$12.27 million08/27/2025$1.28$1.33+3.91%$1.33$1.2612,700 shs$12.56 million08/26/2025$1.33$1.28-3.76%$1.30$1.2711,697 shs$12.08 million08/25/2025$1.29$1.33+3.10%$1.34$1.2829,226 shs$12.56 million Related Companies Relmada Therapeutics Stock Chart PDS Biotechnology Stock Chart Acrivon Therapeutics Stock Chart INmune Bio Stock Chart Sonnet BioTherapeutics Stock Chart ImmuCell Stock Chart Actinium Pharmaceuticals Stock Chart Karyopharm Therapeutics Stock Chart ZIVO Bioscience Stock Chart BioXcel Therapeutics Stock Chart Receive GELS Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Gelteq and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:GELS) was last updated on 9/26/2025 by MarketBeat.com Staff From Our PartnersWhy More Investors Are Using Family Trusts to Protect Their WealthFor many investors, a family trust can be an essential tool for protecting assets, avoiding probate, and ensur...SmartAsset | SponsoredWhat The Silver Boom Could Mean For You…AI, electric vehicles, and even global central banks are quietly fueling record demand for silver. This once-o...Goldco Precious Metals | SponsoredTrump’s national nightmare is herePorter Stansberry and Jeff Brown say a new U.S. national emergency is already underway — and it could trigger ...Porter & Company | SponsoredTrump Devises the Death of the IRS ☠️Trump has just signed an executive order creating America's first-ever National Investment Fund — a game-chang...Angel Publishing | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredNvidia Times 1,000,000Nvidia’s latest AI chip is a $25,000 powerhouse — with 80 billion transistors and the ability to perform 60 tr...Paradigm Press | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredIRS Wants Another Check on Sept 15th—What If You Could Keep It Instead?On September 15th, the IRS collects another round of quarterly tax payments—targeting self-employed profession...American Alternative | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Gelteq Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Gelteq With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free GELS Stock Alerts